HIRONIC

Seoul, Korea – July 25, 2025 – HIRONIC (CEO Jinwoo Lee), a leading company in aesthetic medical devices, announced the successful completion of its 'V-RO Lifting Hands-on Seminar' held recently in Seoul. The seminar featured Dr. Sangsoo Lee from Mirabel Clinic, who delivered a comprehensive program that included theoretical lectures, live demonstrations, and hands-on experiences using HIFU (High-Intensity Focused Ultrasound) and RF (Radio Frequency) technologies for lifting procedures. The event was well-received by attending professionals. During the session, Dr. Lee performed live demonstrations using the V-RO device (export name: New Doublo 2.0), sharing practical treatment protocols and clinical tips that can be applied directly in medical settings. Participants had the opportunity to operate the device themselves, validating its safety and efficacy. V-RO (export name: New Doublo 2.0) is a multi-energy lifting device that combines HIFU and RF technologies. It enables personalized treatments by delivering precise energy to targeted skin layers. HIRONIC emphasized that the seminar once again demonstrated the technological sophistication, clinical applicability, and user satisfaction of the V-RO system. Dr. Sangsoo Lee commented, “It was meaningful to share practical knowledge in a hands-on seminar that went beyond theory to offer immediately applicable insights.” He added, “We plan to continue offering educational opportunities that leverage clinical experiences with the V-RO system.” A HIRONIC representative stated, “V-RO (export name: New Doublo 2.0) is establishing itself as a signature K-beauty lifting solution in the global aesthetic medical market. Based on clinician feedback, we will continue enhancing our products and strengthening international competitiveness.” 

SEOUL, Korea – The 2025 Key Aesthetic Brand Joint Symposium with HUMANS successfully concluded on July 5 at the Voco Gangnam Hotel (IHG) in Seoul. Held under the theme “All About Lifting Boosters,” the symposium brought together leading dermatologists to share clinical insights and the latest trends in skin elasticity and natural lifting treatments. Hosted by the Human Dermatology Network and sponsored by four major aesthetic medical device brands including HIRONIC, the event combined academic depth with practical relevance. Participating dermatologists exchanged treatment know-how and explored the future of personalized patient care through discussions on technological advancements. HIRONIC took the spotlight with its non-invasive skin booster device, SYNERJET. Utilizing high-speed microjet technology, SYNERJET delivers skin booster formulations evenly across the dermis without needles. With a maximum of 20 shots per second and a delivery velocity of 580 m/s, the system minimizes pain and side effects while enhancing treatment efficacy. The device's engineering precision was also notable. SYNERJET features microcurrent stimulation, penetration enhancement, a handpiece cooling system, three interchangeable tips with adjustable injection depth, and 27 preset protocols—ensuring both safety and efficiency. The system enables tailored treatment based on the patient’s skin condition while maximizing convenience for clinicians. As the aesthetic industry evolves from traditional lifting to regenerative and hydrating skin booster therapies, SYNERJET is gaining recognition as a device aligned with this new direction. Its growing clinical adoption and rising satisfaction among medical professionals underscore its value in modern dermatological practice. “The symposium offered valuable insight into rapidly evolving trends and technologies in aesthetic medicine,” the organizers stated. “Thanks to the cooperation of sponsors like HIRONIC, the event was a great success.” They added, “HIRONIC’s continued innovation and R&D efforts are helping elevate treatment quality and patient satisfaction in dermatology. We look forward to building a safer and more effective anti-aging culture in partnership with trusted industry leaders.” Beyond academic exchange, the event received strong engagement for its focus on real-world applications and practical solutions for clinical settings. The organizers plan to hold future symposiums to further enhance the quality and expertise of dermatology services.​ 

Seoul, Korea – HIRONIC, a leading medical aesthetic device manufacturer (CEO Jinwoo Lee), participated in The Aesthetic Show 2025, held in Las Vegas from June 26 to 29 (local time), where it officially unveiled its new product, Synerjet Pro (export name: Synerjet). ​Synerjet is a cutting-edge device that delivers active ingredients into the skin without the use of needles, utilizing micro-jetting technology. This high-speed dispersion method enables the absorption of active substances into the epidermis and dermal-epidermal junction. The company also presented clinical data from tests conducted by the Human Skin Clinical Testing Center, comparing absorption efficacy against traditional topical application methods. During the exhibition, HIRONIC representatives introduced the mechanism and technology behind Synerjet to global visitors. According to the company, buyers from North and Latin America showed strong interest in the product, asking detailed questions about its structure and potential applications. "Synerjet is a versatile skin booster delivery platform designed to align with the evolving trends in global aesthetic treatments," said Sungho Lee, CMO of HIRONIC Global Marketing Office. Founded in 2007, HIRONIC developed Korea’s first HIFU-based aesthetic system, DOUBLO, and has since expanded its portfolio to include picosecond lasers, micro-jetting, RF (radiofrequency), and cold plasma technologies. With a solid foundation of proprietary technology and IP, the company continues to strengthen its global presence. HIRONIC plans to leverage its participation at The Aesthetic Show 2025 as a launchpad to expand international activities, with Synerjet at the forefront of its global strategy.​ 

HIRONIC (KOSDAQ: 149980), a specialist in medical aesthetic devices, announced on June 10 that it has signed a supply agreement with Dynamic Medical Technologies (DMT), a leading distributor of aesthetic medical equipment in Taiwan, for the distribution of its flagship products. Under the agreement, HIRONIC will supply three of its core products over the next three years upon certification: the “Ultra Vera,” a high-intensity focused ultrasound (HIFU) device for women's health; the newly launched needle-free injector “Synerjet Pro”; and “MIGLOW,” a microwave-based lifting device. The total supply volume is expected to reach up to 227 units over three years, valued at approximately KRW 7 billion. In particular, Synerjet Pro and MIGLOW are key new innovations launched by HIRONIC in 2025 as part of its strategic product portfolio. The exclusive partnership aimed at rapidly increasing market share in Taiwan right after product launch underscores the significance of this deal. Dynamic Medical Technologies, led by Chairman Fu Hui-Tung, is Taiwan's top-tier company in the aesthetic medical field, distributing global brands such as Ulthera, Candela, Thermage, and Fotona. It also handles pharmaceuticals and fillers from major companies like Medytox, while operating 49 clinical centers and clinics. Founded in 2003 and listed on the Taiwan Stock Exchange since December 2010, DMT is headquartered in Taipei with four local branches and subsidiaries in Hong Kong, Guangzhou, and Beijing. It is also part of the Excelsior Healthcare Group. A representative from HIRONIC overseeing the Taiwan market stated, “Taiwan is a key market with high demand for aesthetic treatments. This agreement will serve as a bridgehead for expanding our new products—Synerjet and MIGLOW—across Asia. We aim to enhance brand credibility and deliver both treatment efficacy and customer satisfaction through close collaboration with our local partner.” HIRONIC is a medical device manufacturer specializing in dermatological equipment. It develops and produces a variety of energy-based solutions including HIFU, laser, and RF technologies. Since its KOSDAQ listing in 2014, the company has consistently grown in both domestic and international markets, with a vision to lead the global aesthetic medical field through innovation and technology.​ 

HIRONIC, a global leader in non-invasive medical aesthetic technologies, announced that it has signed an exclusive contract with Shiho Yano—model, author, and wellness expert—as its official brand ambassador for Southeast Asia and Korea.    The partnership centers on HIRONIC’s flagship device, “V-RO Advance” (export name: NEW DOUBLO 2.0), the newly launched needle-free energy device “SYNERJET,” and the women-specific HIFU device “TITY.” Shiho Yano will serve as the official promotional model, representing the brand across campaigns and public engagements. Shiho Yano is widely known for her wellness-based lifestyle that emphasizes balance and natural beauty. HIRONIC cited the alignment between her image and the company's brand philosophy as a key reason for the appointment. The global aesthetic market is increasingly embracing the "well-aesthetics" trend, a fusion of advanced beauty technologies and wellness. In line with this, HIRONIC is focusing on developing non-invasive yet effective treatment solutions. The appointment of Shiho Yano as an exclusive ambassador is a strategic move to embody and communicate the brand’s identity. At the heart of this partnership is the global launch of HIRONIC’s next-generation device, “SYNERJET PRO™.” The device combines high-pressure jet injection, electroporation, and low-temperature plasma technologies to deliver active ingredients deep into the skin without needles, catering to customers who prioritize safety and wellness. Seongho Lee, CMO of HIRONIC, stated, “HIRONIC is redefining the standard of aesthetic care with smarter and less invasive technologies. Shiho Yano is a perfect fit with this direction, and we anticipate she will powerfully convey our message in both the Korean and Southeast Asian markets.” Shiho Yano commented, “HIRONIC is more than just a technology company—it offers a new standard for self-respect and self-love. Its values align with my own philosophy on skin health and beauty, making it meaningful for me to join as a brand model.”​ 

HIRONIC, a global leader in non-invasive medical aesthetic technology, has successfully hosted its inaugural 'HIRONIC Innovation Summit 2025. Asia Edition' in Bangkok, Thailand on June 5th. The event brought together approximately 100 medical professionals and medical distribution industry representatives from South Korea, Thailand, Vietnam, Malaysia, Indonesia, Myanmar, and other countries. Across four in-depth clinical sessions, speakers presented the latest approaches to skin rejuvenation, covering multi-layered face and body lifting, advanced scar treatment, and next-generation needle-free drug delivery technologies.One of the keynote lectures was delivered by Dr. Wonkyu Hong, Director and dermatologist at Human Dermatology Clinic and Executive Director of the Human Clinical Trial Center in South Korea. Dr. Hong explored the rapidly evolving role of needle-free technology in aesthetic medicine, sharing his clinical experience while emphasizing both its therapeutic advantages and its significant market growth potential driven by increasing patient demand for non-invasive rejuvenation solutions.Dr.Thitikom Limrattanamekha, founder and CEO of Optima Aesthetics in Thailand and an experienced laser specialist in scar treatment, skin quality improvement, and pigmentation management, shared his expertise on combining pico laser and RF microneedling to achieve highly effective outcomes in complex scarring cases. His presentation highlighted how advanced combination protocols are reshaping non-surgical treatment approaches and expanding therapeutic options for physicians worldwide.The symposium also provided a platform to showcase the clinical advancements and growing market relevance of HIRONIC's flagship export technologies, including New Doublo 2.0™, PICOHI™, and the latest needle-free delivery system Synerjet PRO™. Sasha Borovtsova, Head of Global Marketing Office at HIRONIC, stated, "This summit not only showcased the real-world clinical applications of our technologies but also underscored the accelerating global demand for safer, more versatile, and highly effective aesthetic solutions. As innovation continues to drive market growth, HIRONIC remains committed to advancing technology and strengthening global expertise and partnerships through events like the HIRONIC Innovation Summit." 

HIRONIC Hosts 1st Innovation Summit in Asia – A Gathering of Aesthetic Industry Leaders On June 5, 2025, HIRONIC will host the 1st HIRONIC Innovation Summit 2025 – Asia Edition at Asia Hotel in Bangkok, Thailand. This half-day event brings together top dermatologists and aesthetic experts across Asia to share clinical insights and explore the latest advances in medical aesthetic technologies including New Doublo 2.0™, SYNERJET™, and PICOHI™ 300. Featured speakers include Dr. Thanadol Janwaowam, Dr. Tonghathai Tangsinnamkong, Dr. Thitikom Limrattanamekha, and Dr. Wonkyu Hong, presenting live case studies and innovations in non-invasive lifting, skin rejuvenation, and needle-free injection technology. The summit promises to deliver cutting-edge knowledge, empower regional distributors, and foster stronger clinical and business partnerships across Asia.​  

The 25th edition of the HIRONIC GLOBAL NEWSLETTER has been released.Please send an email to marketing@hironic.com if you have any questions.Thank you!    

The HIRONIC Distributor Training program is back for its June schedule! Enrollment is now open, and we invite all our international distribution partners to join us in this comprehensive educational initiative.  This training program aims to empower your sales and marketing teams with the knowledge and skills necessary to effectively represent the HIRONIC brand and drive successful market penetration in your respective regions.  Our expert instructors will guide you through interactive sessions, hands-on demonstrations, and case studies.   

HIRONIC Co., Ltd. (CEO Jinwoo Lee), a global leader in medical aesthetic technologies, has been awarded the Grand Prize in the Medical Aesthetic Device category at the 2025 Service Customer Satisfaction Awards, hosted by MoneyToday. The ceremony took place at the Korea Press Center in Seoul. This marks the company’s eighth consecutive year receiving this distinguished recognition. The Service Customer Satisfaction Awards are presented to companies across various industries that deliver exceptional service quality and demonstrate excellence in customer satisfaction. HIRONIC's consistent commitment to customer-centered innovation and advanced product development has once again earned industry-wide acclaim. HIRONIC is renowned for pioneering integrated treatment technologies in the aesthetic field. Its flagship platform, V-RO ADVANCE (internationally known as New Doublo 2.0™), combines High-Intensity Focused Ultrasound (HIFU), Radio Frequency (RF), and Microneedling into a single, multifunctional system—ushering in a new era of personalized, non-invasive skin rejuvenation. Expanding its global reach, HIRONIC recently introduced two advanced transdermal delivery solutions: SYNERJET and SYNERJET PRO™. Designed respectively as a cosmetic device for the domestic market and a medical device for international distribution, both systems leverage Micro-Jetting, Electroporation, and Plasma technologies to enable precise and uniform delivery of active ingredients. Notably, SYNERJET PRO™ is engineered to meet stringent medical regulations across multiple markets. “SYNERJET and SYNERJET PRO™ were developed to align with differing regulatory and clinical needs around the world,” a company spokesperson stated. “We are actively pursuing international certifications and expanding strategic partnerships to enhance the competitive positioning of SYNERJET PRO™ in the global aesthetic medicine landscape.” Commenting on the award, CEO Jinwoo Lee remarked, “Receiving this honor for the eighth consecutive year is a profound privilege and responsibility. At HIRONIC, we are committed to sustainable growth built on technological excellence, clinical integrity, and customer trust. We will continue to lead the evolution of aesthetic medicine with innovation that not only satisfies, but truly inspires our customers.” 

HIRONIC Co., Ltd a leading company in energy-based medical aesthetic devices, showcased its new product SYNERJET PRO™ at Dubai Derma 2025, the largest medical aesthetics exhibition in the Middle East. At the event, HIRONIC introduced SYNERJET PRO™, a needle-free drug delivery device, as its flagship product. The system combines Micro-Jetting, Electroporation, and Plasma technologies to deliver active ingredients uniformly into the dermal layer. Designed to minimize the discomfort and psychological burden associated with traditional needle injections, SYNERJET PRO™ drew attention for its potential application in various areas such as skin boosters and anti-aging treatments. During the exhibition, the product received positive feedback from local medical professionals, who noted its strong alignment with the growing demand in the Middle Eastern medical aesthetics market. Prior to Dubai Derma, HIRONIC had already introduced SYNERJET PRO™ at several major international exhibitions, including IMCAS Paris 2025 in January and AAD and KIMES 2025 in March. “The SYNERJET PRO™ is one of HIRONIC’s next-generation global strategy products, developed to overcome the technical limitations of previous needle-free injectors,” said a HIRONIC representative in charge of the Middle East region. “The enthusiastic response at Dubai Derma has reinforced our confidence in both the product strategy and brand direction.” HIRONIC is also scheduled to participate in IMCAS Asia 2025, to be held this June in Bangkok, where the company will conduct live demonstrations and academic sessions centered on SYNERJET PRO™. 

The 24th edition of the HIRONIC GLOBAL NEWSLETTER has been released.Please send an email to marketing@hironic.com if you have any questions.Thank you!    

During the recent Korea International Medical & Hospital Equipment Show (KIMES) from March 20th to 23rd, HIRONIC showcased an extensive range of medical aesthetic devices, including its flagship products such as the NEW DOUBLO 2.0™, PICOHI™, and SILKRO™. The event also marked the debut of the latest innovations, SYNERJET™ and MIGLOW™, which attracted significant attention from international partners. The company reported an overwhelming turnout, with robust interest and engagement from attendees, highlighting HIRONIC's continued commitment to innovation and global market leadership in medical aesthetics technology. 

On the evening of March 21st, Friday, the Park Hyatt Seoul Hotel successfully hosted the "HIRONIC VVIP Partners Meeting 2025." The event brought together global partners and Key Opinion Leaders (KOLs) to unveil new products, share the latest technologies, and provide a networking dinner. Notably, the successful use cases of the New Doublo 2.0 and the innovative application techniques of the newly launched SYNERJET PRO drew significant attention from the participants.  The dinner also served to strengthen partnerships and promote mutual global growth, highlighted by the VIP Partners awards ceremony. Following the awards, distinguished experts delivered high-level lectures showcasing their flagship products. The first lecture was presented by Ting Mao Chou, CEO of Victory Eight from Taiwan, discussing the "New Doublo Taiwan Success Story." This was followed by Dr. Thitikom Lamrathanamekha, a representative from Optima Aesthetics in Thailand and a HIRONIC global KOL, who introduced new treatment techniques in the lecture "New Doublo 2.0 New Technique: Triple Firm Protocol." The final lecture was given by Dr. Wonkyu Hong, a HIRONIC global KOL, who highlighted the innovative technology of the 3rd Generation Needle-Free Injector, SYNERJET PRO, in his presentation "Maximizing Penetration Synergy of Microjetting, Electroporation, and Plasma," which received a warm response from the audience.This VVIP Partners Meeting was a meaningful time to reinforce close cooperation with our global partners and share our latest products and clinical cases. We remain committed to leading the global aesthetic medical device market with our innovative technologies.​      

Join us for an exclusive HIRONIC Global Business Briefing1) Date: March 21st, 20252) Time: 2 PM - 4 PM3) Location: COEX, South Korea, Room 311, 3FDiscover the future of aesthetic with our newly launched 3rd Generation Needle-Free Synergy Injector, SYNERJET PRO™ (export edition). Don’t miss out on learning about our upcoming product releases and exploring global business opportunities.Stay ahead in the industry with HIRONIC.